Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
27 Results for "
S configuration
" in MedChemExpress (MCE) Product Catalog:
Products (27)
27 Results for "S configuration" in MCE Product Catalog:
1
Target:
Cat. No.: HY-145728B
Purity: 97.08%
Synonyms: (R/S)-ISIS-2302
Target:
Research Areas:
(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and trafficking to the site of inflammation.
Cat. No.: HY-W001294
CAS No.: 109431-87-0
Research Areas:
(R)-(-)-N-Boc-3-pyrrolidinol is a chiral pyrrolidine derivative. After undergoing configuration inversion via the Mitsunobu reaction, (R)-(-)-N-Boc-3-pyrrolidinol can serve as a precursor for the (3S)-aryloxypyrrolidine fragment, which is used to construct key intermediates of FXa inhibitors (such as DX-9065a (HY-10722)) and various chiral drugs. (R)-(-)-N-Boc-3-pyrrolidinol can be applied in studies related to arrhythmia .
Cat. No.: HY-W012885
CAS No.: 53562-86-0
Cat. No.: HY-B0196B
CAS No.: 93413-44-6
Target:
Research Areas:
(S)-Venlafaxine is the (S)-configuration of Venlafaxine. Venlafaxine is an orally active, potent serotonin (5-HT)/norepinephrine (NE) reuptake dual inhibitor. Venlafaxine is an antidepressant agent .
Cat. No.: HY-177712
CAS No.: 1599530-54-7
Target:
Research Areas:
RORγt inverse agonist 36 (S configuration of Compound 16) is a RORγt inverse agonist. RORγt inverse agonist 36 can be used for the research of inflammation and immunology .
Cat. No.: HY-106841A
CAS No.: 138681-29-5
Synonyms: (-)-Draflazine; (S)-R-75231; (S)-R88021
Target:
Research Areas:
(S)-Draflazine ((-)-Draflazine) is the (S)-configuration of Draflazine (HY-106841). (S)-Draflazine is a potent blocker of nucleoside transport .
Cat. No.: HY-122294
CAS No.: 53716-44-2
Target:
Research Areas:
Rociverine is an anticholinergic compound with smooth muscle relaxant activity. Rociverine showed different binding modes in five cloned muscarinic receptors. The cis stereoisomer of Rociverine showed a higher affinity change compared to the trans stereoisomer. The (1R,2R) configuration of Rociverine showed significantly higher affinity, even up to 240 times. The (1S,2S) configuration of Rociverine is very important for binding selectivity .
Cat. No.: HY-135386
CAS No.: 957229-52-6
Target:
Research Areas:
5β-Dutasteride is the S configuration of Dutasteride. 5β-Dutasteride is a potent inhibitor of both 5 alpha-reductase isozymes .
Cat. No.: HY-100449A
CAS No.: 1224444-55-6
Target:
Research Areas:
(S)-AL 8810 is an 11β-fluoro analog of PGF2α that acts as a potent and selective antagonist at the FP receptor. (S)-AL 8810 is the C-15 epimer of AL 8810, having the
inverse, (S), or "natural" configuration at C-15 relative to AL 8810, which is 15-(R) .
Cat. No.: HY-30220R
CAS No.: 20312-36-1
Synonyms: L-(-)-3-Phenyllactic Acid (Standard)
Cat. No.: HY-W797383A
CAS No.: 2986073-45-2
Research Areas:
(S)-Phthalimidinoglutarimide-6-piperazine is the (S)-configuration of Phthalimidinoglutarimide-6-piperazine (HY-W797383). (S)-Phthalimidinoglutarimide-6-piperazine is an E3 ligase ligand-linker conjugate. (S)-Phthalimidinoglutarimide-6-piperazine can be used for synthesis of PROTAC SMARCA2 degrader-35 (HY-176871) .
Cat. No.: HY-W753181
Synonyms: L-(-)-3-Phenyllactic Acid-13C9
Cat. No.: HY-18941B
CAS No.: 176027-90-0
Synonyms: (rel)-LY354740; (rel)-Eglumetad
Target:
Research Areas:
(rel)-Eglumegad ((rel)-LY354740) is a relative configuration of Eglumegad (HY-18941). Eglumegad is a highly potent and selective group II (mGlu2/3) receptor agonist with EC50s of 5 and 24 nM for transfected human mGlu2 and mGlu3 receptors, respectively .
Cat. No.: HY-169803
CAS No.: 113243-00-8
Target:
Research Areas:
L-657926 is a stereoselective antagonist of the thromboxane A2 (TxA2) receptor, composed of (-)-9-chlorobenzyl-6-fluoro-1,2,3,4-tetrahydrocarbazol-1-yl acetic acid and (+)-9-chlorobenzyl-6-fluoro-1,2,3,4-tetrahydrocarbazol-l-yl acetic acid. The IC50s of (-) and (+) configurations for TxA2 are 0.27 nM and 124 nM, respectively.
Cat. No.: HY-W756265
Research Areas:
(R)-(-)-N-Boc-3-pyrrolidinol-d4 is the d4-labeled (R)-(-)-N-Boc-3-pyrrolidinol (HY-W001294). (R)-(-)-N-Boc-3-pyrrolidinol is a chiral pyrrolidine derivative. After undergoing configuration inversion via the Mitsunobu reaction, (R)-(-)-N-Boc-3-pyrrolidinol can serve as a precursor for the (3S)-aryloxypyrrolidine fragment, which is used to construct key intermediates of FXa inhibitors (such as DX-9065a (HY-10722)) and various chiral drugs. (R)-(-)-N-Boc-3-pyrrolidinol can be applied in studies related to arrhythmia .
Cat. No.: HY-E71084A
Target:
Research Areas:
2-Haloacid dehalogenase (configuration-inverting) (EC 3.8.1.10) can dehalogenate (S)- and (R)-2-haloalkanoic acids to the corresponding (R)- and (S)-hydroxyalkanoic acids, respectively, accompanied by an inversion of configuration at the C-2 position.
Cat. No.: HY-E71084B
Target:
Research Areas:
2-Haloacid dehalogenase (configuration-retaining) (EC 3.8.1.11) can dehalogenate (S)- and (R)-2-haloalkanoic acids into the corresponding (S)- and (R)-hydroxyalkanoic acids, respectively, while retaining the configuration at the C-2 position.
Target:
Cat. No.: HY-N18105
CAS No.: 53938-05-9
Category:
Alkaloids Other Alkaloids Celastraceae Gymnosporia arbutifolia (Hochst. ex A.Rich.) Loes. Plants
Target:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
